This application is for a five year renewal of the Alzheimer's Disease Research Center (ADRC) at the University of Kentucky's Sanders-Brown Center on Aging. The long-term objective is to build on the existing broad-based AD Program to gain an understanding of the pathogenetic mechanisms in AD with the eventual goal of prevention or treatment of the disease. The ADRC has a multidisciplinary program including basic and clinical research, exemplary clinical care and neuropathological activities, satellite clinics for rural and minority subjects, and a broad spectrum of educational and training programs, all of which are responsive to investigators, health care delivery professionals, AD families, and needs of the community, state, and region. The ADRC provides an important resource for and is complemented by two AD program project grants, a major epidemiologic study and other R01 AD grants. The ADRC receives strong support from the University administration and is housed in a building dedicated to aging and AD research. This application consists of five cores, three projects, and two pilot projects. The Administrative Core organizes, coordinates, and supervises all ADRC activities. The Biostatistical and Data Management Core maintains clinical, neuropathologic and research databases and provides statistical expertise in experimental design and data analysis. The Clinical Core evaluates and longitudinally follows AD patients and control subjects for research studies and subsequent postmortem studies. It recruits and follows a large series of normal volunteer control subjects and maintains Satellite Diagnostic and Treatment Clinics for rural and minority subjects in the Appalachian area of eastern Kentucky and in Nashville, Tennessee in conjunction with Vanderbilt/Meharry Medical Schools. The Neuropathology Core provides diagnoses of autopsied AD patients and control subjects for a wide spectrum of research projects and maintains a tissue bank. The Research Training and Information Transfer Core disseminates information about AD to investigators, health care professionals and the lay community, and facilitates research training of investigators and health care professionals. The research projects include the role of excitotoxicity, amyloid beta peptides and oxidative changes in neuron death in AD (Project 1), the role of neuronal insults in cytoskeletal alterations in AD (Project 2), and development of cholinergic neurons for transplantation in AD (Project 3). Pilot Project 1 will investigate the role of S100beta in AD and Pilot 2 will study the substrate of intellectual decline in vascular dementia using magnetic resonance imaging and spectroscopy.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005144-15S1
Application #
2841954
Study Section
Special Emphasis Panel (ZAG1 (51))
Project Start
1985-09-30
Project End
2000-04-30
Budget Start
1998-08-01
Budget End
1999-04-30
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Other Health Professions
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Broster, Lucas S; Li, Juan; Wagner, Benjamin et al. (2018) Spared behavioral repetition effects in Alzheimer's disease linked to an altered neural mechanism at posterior cortex. J Clin Exp Neuropsychol 40:761-776
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Reed, Rebecca G; Greenberg, Richard N; Segerstrom, Suzanne C (2017) Cytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: The moderating effect of beta blockade. Brain Behav Immun 61:14-20
Li, Juan; Broster, Lucas S; Jicha, Gregory A et al. (2017) A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging. Alzheimers Res Ther 9:3
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Wei, Shaoceng; Kryscio, Richard J (2016) Semi-Markov models for interval censored transient cognitive states with back transitions and a competing risk. Stat Methods Med Res 25:2909-2924

Showing the most recent 10 out of 236 publications